We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Urine Particle Analyzer Compared with Standard Methods

By LabMedica International staff writers
Posted on 20 Nov 2017
Urinary tract infections (UTIs) are characterized by the presence of microbial pathogens within the urinary tract, and they represent one of the most common infections identified in both hospitalized and clinic patients. More...
Most UTIs are easily treated without difficulty.

In certain patient populations, such as children, pregnant women, and the elderly, significant complications may arise. The symptoms observed with UTIs are diverse and can range from mild irritation with voiding to bacteremia or even sepsis. When sepsis is present, it can lead to death if it is not diagnosed and treated early.

Medical scientists working at Prescient Medicine (Hummelstown, PA, USA) and their colleagues compared data from urine samples collected in sterile containers for bacterial culture and microscopic analysis during a 3-month period in a laboratory at a 572-bed, acute-care hospital. Upon receipt, one sample was used to inoculate a 5% sheep blood agar and a MacConkey agar plate with a 0.001-mL calibrated loop.

The second sample was analyzed for bacteria and leukocytes with the Sysmex UF-1000i urine analyzer (Sysmex Corporation, Kobe, Japan) which is a fully automated, fluorescent flow cytometer that categorizes red blood cells, white blood cells, epithelial cells, small round cells, sperm cells, crystals, and pathologic and hyaline casts, yeast, and bacteria. The second sample was also analyzed by urinalysis-associated microscopy for the presence of epithelial cells, leukocytes, yeast, and bacteria.

Urine cultures showed no growth in 2,034 samples (50%) and growth of less than 104 colony-forming units (CFUs)/mL in 1,812 samples (45%). Of the 4.033 results, 754 samples (19%) showed bacterial growth of 105 CFUs/mL or more, and 190 samples (5%) were considered contaminated specimens because they contained multiple species. However, if the growth of bacteria exceeded the definition of a negative result, they were considered to be positive, even though the likelihood of a UTI was low in those patients. Of the culture-positive samples, the most commonly identified microorganisms were Escherichia coli and Klebsiella spp, which is consistent with known epidemiologic data.

Of the 4,033 unique urine samples obtained from adult patients, 2,736 (67.8%) specimens had positive white blood cell counts and bacteria and 1,215 (30.1%) specimens had negative white blood cell counts and bacteria as reported by the UF-1000i. The negative predictive value for any positive culture in the adult population included in the study was 95.5%, and the negative predictive value for positive cultures containing growth of 100,000 or more CFUs was 99.3% using the Sysmex UF-1000i. There were 373 unique urine specimens collected in pediatric patients and using the UF-1000i method, 269 specimens (72%) had positive white blood cell counts and bacteria, and 104 (27.9%) tested negative for an elevation in white blood cell counts and bacteria.

The authors concluded that the Sysmex UF-1000i showed 98% sensitivity and 93.7% specificity with a 95.5% negative predictive value. Thus, a negative screen with the UF-1000i using defined thresholds for white blood cell counts and bacteria was likely to be a true negative, decreasing the need for presumptive antibiotics. The study was published in the November 2017 issue of the journal Archives of Pathology & Laboratory Medicine.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image: The model combines digitized tumor histopathology, clinical variables, and a 42-gene molecular panel using AI to generate a unified recurrence risk prediction (Image Credit: Shutterstock)

Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing

Predicting which patients with early-stage breast cancer will develop distant recurrence remains difficult, complicating decisions about long-term therapy and surveillance. Widely used genomic assays are... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.